Geniculate herpes zoster

Summary

Geniculate herpes zoster (MONDO:0005769) is a disease and 2 clinical trials. A subtype of herpes zoster — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: 1-9 / 100 000 (United States) [Orphanet-validated]
• Clinical trials: 2

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

Type	Class	Value	Geography	Validation
Annual incidence	1-9 / 100 000	5	United States	Validated

Identifiers

Disease identifiers

Field	Value
Canonical name	geniculate herpes zoster
Mondo ID	MONDO:0005769
EFO	EFO:0007281
Orphanet	3020
DOID	DOID:9210
NCIT	C84763
SNOMED CT	95670000
UMLS	C0017409
MedGen	6581
GARD	0007525
NORD	1647
Anatomy (UBERON)	UBERON:0001647
Is cancer (heuristic)	no

Also known as: facial nerve palsy due to herpes zoster infection · facial nerve palsy due to VZV · facial nerve paralysis due to VZV · Herpes Zoster Oticus · Hunt syndrome (formerly) · Hunt’s syndrome (formerly) · Ramsay Hunt Syndrome · Ramsay Hunt syndrome · Ramsay Hunt syndrome type 2 (formerly)

Disease family

This is a subtype of herpes zoster. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › viral infectious disease › primary viral infectious disease › Herpesviridae infectious disease › varicella zoster infection › herpes zoster › geniculate herpes zoster

Related subtypes (2): ophthalmic herpes zoster, zoster sine herpete

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT05424302	Not specified	RECRUITING	Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
NCT06542289	Not specified	NOT_YET_RECRUITING	Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy